CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares.
CardioGenics Trading Down 100.0 %
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
See Also
- Five stocks we like better than CardioGenics
- Consumer Staples Stocks, Explained
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What Investors Need to Know to Beat the Market
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Profit From Growth Investing
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
